Date | Subject | Author | Discuss |
---|
29/9/2021 19:34:59 | Nice to see Newlands faith given their experience and background… |  strategicinvestor2 | |
29/9/2021 17:10:41 | monique newland increases holding- is she a director? |  ali47fish | |
28/9/2021 19:08:36 | It’s easy to forget why I bought into Kromek... the business taking a turn and due to make a profit (despite the large spend on IP). Plus the potential of the biological pathogen detector. To sell now as tempting as it is sometimes, as the share price is heading down with no obvious reasons or news - is as Warren Buffet would say ‘watching the scoreboard instead of the pitch’. |  aqc888 | |
28/9/2021 09:25:30 | Well there's some appetite for Kromek this morning(yesterday pm) that's 3 x 100k & a delayed 250k from 8.01am. And plenty of other buys too. I'm holding out until the end of the year too, atleast. Surely has to be some positive update by then!?! |  davethechef | |
28/9/2021 09:02:58 | It gave me some comfort to see Kromek have been patenting a lot in the last year. Mostly to do with the biological pathogen detector I presume. I’m a lot happier holding through these dips knowing that not only are they having their best financial year (not due to make a loss!) 80% of analysts forecast for the financial year already met, despite the spend on being 4th in the Intellectual Property 100 list. |  aqc888 | |
28/9/2021 00:31:55 | Can anyone explain why its been implied in interviews and emails to investors that the Covid detector works fantastically well but they haven’t bothered to RNS what on earth is going on right now?
Another 6 weeks minimum now of nothing. Is the thing finished but struggling to find buyers or is it still being tweaked? What is going on??? There unprofessionalism in regards to updating the market has caused a sell off. I’ve sold half myself these last few weeks and seems like many others have also. Maybe they want us to sell before they announce a huge order? Maybe there are no orders? Smoke and mirrors ? |  ark87 | |
28/9/2021 00:31:55 | kmk have some great tech but the orders are usually small. The question I am starting to ask myself is when you factor in overheads are they making this great technology AT A LOSS??
I’ve done enough moaning here now will be my last post. I’ll be back to apologise if we ever do see serious upwards movement in the share price |  ark87 | |
27/9/2021 22:14:57 | So Covid will probably morph into something like the common cold in the usual couple of years time frame - an H5N7 flu strain could be a real worry for the future and a vaccine for HIV could be a long way off.
IMO GLA |  simithy | |
27/9/2021 16:55:01 | as they cant buy during a closed period, any director buys inadvertently means nothing price sensitive happening for at least 6 weeks. Otherwise the purchase would be under scrutiny |  fanramptastic mate | |
27/9/2021 16:32:20 | If it’s the start of a flurry of director buys it could have a positive effect. However I’d be a lot more at ease knowing they’ve invested more significant amounts. £50k buys would make me happier |  aqc888 | |
27/9/2021 16:29:37 | A token gesture. What exactly are the regulations for insiders such as this director buying shares, when he must surely have access to detailed information on how the detectors progress is going? Better details than the market. |  aqc888 | |
27/9/2021 16:29:28 | Directors buy- seems to show insiders confidence |  strategicinvestor2 | |
27/9/2021 14:36:22 | £15k Directors buy. Seems like desperate attempt to stop the selling. |  ark87 | |
27/9/2021 13:37:32 | Indeed.
The Sciences and scientists tend to be highly specialised.
Very, very rare that they are inter-disciplinary in my experience.
CZT is one field and one specialisation - which is clearly the core activity and apparent strategy of Kromek.
But a new product based on a fundamentally different branch of science - biotechnology- involving DNA-Sequencing is something completely different from CZT based applications.
I'd personally like to understand better the resources and commitment - financial, technical and human - that the Company has to support a new development based on a biotech product and how many dedicated DNA-Sequencing specialists/ biotechnologists they have to develop and support this new activity.
all imo.dyor. qp |  quepassa | |
27/9/2021 13:16:35 | And seemingly unaware of the very differing challenges a error correcting retro virus - Covid, a genetically diverse virus - flu and a mutation engine HIV pose. |  simithy | |
27/9/2021 12:56:23 | True, but do you trust the scientists at Kromek?
That’s the issue that I struggle with as an investor. The scientists repeatedly offer class leading products and achievements. While the Board of Directors as Skid35 states consistently over promise and underdeliver.
Good to see those scientists are clearly busy at work as my previous link shows. The reason behind why I did a searching for “Kromek patents” on google and found that article was precisely because I have no confidence in the BoD when I hear the ceo talk of IP they poses in regards to the pathogen detectors.
Skid35s comment “ The share price shows the market still really doesn't trust the BOD”, certainly applies to myself. |  aqc888 | |
26/9/2021 21:44:55 | Apologies, it was ranked 4th based on a mix of five areas: brand and reputation, patents, critical databases, software and trade secrets. Not exclusively on patents. |  aqc888 | |
26/9/2021 21:37:54 | Interesting article... apparently Kromek have registered the 4th highest number of patents of any company in the U.K.
Hopefully some of those patents will start generating us some profit. Article was from June 2021, so I’d guess most of the patents will be related to the biological pathogen detector. |  aqc888 | |
24/9/2021 20:34:31 | It concerns me a lot that the main shareholders in Kromek are Hargreaves landsdown and ajbell etc. All small private unprofessional investors. Large funds have left long ago due to the weak management and failure to deliver. What we’re left with is a very low valuation at Kromek that could potentially outperform if the scientists at Kromek can carry the dead weight of the management. I still feel the underlying business is doing ok - in so much as they don’t need any further fundraising’s. But this biological pathogen detector on the side is all that interests me. Can the Kromek scientists excellence outweigh the poor management? Read skid35s research on lse regarding outrageous payments to the departing cfo amongst others points he rightly identifies as signs of weak and poor management. It’s a very erratic stock, but there’s enough here to keep me holding on for another few months. |  aqc888 | |
24/9/2021 20:03:52 | Dexter1612,
You summed him up perfectly! |  davethechef | |